T. Tourlentes

Risk-Taking Behavior

T. Tourlentes, 1993 .

Endogenous Metabolic Factor in Schizophrenic Behavior

T. Tourlentes, H. Himwich, K. Matsumoto, 1964, Science.

Chlorpromazine and communication processes.

T. Tourlentes, D. Hurd, A. Hunsicker, 1958, A.M.A. archives of neurology and psychiatry.

Relevance of drug-induced extrapyramidal reactions to behavioral changes during neuroleptic treatment. II. Combined treatment with trifluoperazine-amobarbital.

T. Tourlentes, H. Himwich, G. Brune, 1962, Comprehensive psychiatry.

Relevance of drug-induced extrapyramidal reactions to behavioral changes during neuroleptic treatment. I. Treatment with trifluoperazine singly and in combination with trihexyphenidyl.

T. Tourlentes, H. Himwich, C. Morpurgo, 1962, Comprehensive psychiatry.

CLINICAL TRIAL OF FLUPHENAZINE ENANTHATE-- A LONG-ACTING INJECTABLE TRANQUILIZER.

T. Tourlentes, S. L. Pollack, A. Zocchi, 1964, The American journal of psychiatry.

HYPERTENSION WITH METHIONINE IN SCHIZOPHRENIC PATIENTS RECEIVING TRANYLCYPROMINE.

T. Tourlentes, H. Himwich, H. Berlet, 1964, The American journal of psychiatry.